. Diagnostic Levels of C-reactive protein (CRP), epinephrine (Ep), cortisol (Cor), and norepinephrine (NE) in Patients Undergoing Laparoscopic Surgery for Gallstones receiving Anti-inflammatory
Diagnostic Levels of C-reactive protein (CRP), epinephrine (Ep), cortisol (Cor), and norepinephrine (NE)
Abstract
Objective: To investigate the effect of anti-inflammatory and choleretic soup on CRP, E, Cor, NE and gallbladder function recovery in patients after laparoscopic cholecystectomy. Methods: 111 patients with gallstones who underwent laparoscopic surgery in the hospital from November 2019 to March 2024 were selected, and all patients were separated into two groups adoptting the random number method. The control group (n=56) received extracorporeal circulation treatment alone; The experimental group (n=55) were combined with the application of anti-inflammatory bile soup on its basis. Finally, to compare and analyze the differences in the levels of C-reactive protein (CRP), epinephrine (Ep), cortisol (Cor), and norepinephrine (NE) between the two groups, and evaluate the effect of gallbladder function recovery. Results: Three months after treatment, the levels of CRP, Ep, Cor, and NE in both groups decreased compared with those before the experiment, and the levels of each index in the experimental group were lower than those in the control after treatment (P<0.05). In addition, the gallbladder wall thickness and fasting gallbladder volume (FV) among patients were smaller than pre-treatment, and the gallbladder contraction rate was also larger. The experimental group's various indexes of gallbladder function evaluation were better than control (P<0.05). Conclusion: The application of anti-inflammatory and choleretic soup in patients after laparoscopic cholecystectomy helps to improve the performance of some parts of the body, enhance the recovery of gallbladder functional indexes, and lift the life quality for the prognosis and rehabilitation of patients.
References
[2]H. Ji, Y. Hou, X. Cheng, F. Zhu, C. Wan, L. Fang. “Association of Laparoscopic Methods and Clinical Outcomes of Cholecystolithiasis Plus Choledocholithiasis: A Cohort Study.” TURK J GASTROENTEROL, vol. 34, no. 1. pp. 35-42. Jan. 2023. doi:10.5152/tjg.2022.22110
[3]K. Mishra, A. Behari, P. Shukla, Y. Tsuchiya, K. Endoh, T. Asai, T. Ikoma, K. Nakamura, V. K. Kapoor. “Risk factors for gallbladder cancer development in northern India: A gallstones-matched, case-control study.” INDIAN J MED RES, vol. 154, no. 5 pp. 699-706, Nov. 2021. doi:10.4103/ijmr.IJMR_201_19
[5]B. Wang, A. Huang, M. Jiang, H. Li, W. Bao, K. Ding, Z. Jiang, G. Zhao, H. Hu. “Risk Factors for Early Recurrence of Gallstones in Patients Undergoing Laparoscopy Combined With Choledochoscopic Lithotomy: A Single-Center Prospective Study.” FRONT SURG, vol. 8, pp. 759390. Nov. 2021. doi:10.3389/fsurg.2021.759390
[6]I. Ahmed, K. Innes, M. Brazzelli, K. Gillies, R. Newlands, A. Avenell, R. Hernández, J. Blazeby, B. Croal, J. Hudson, G. MacLennan, K. McCormack, A. McDonald, P. Murchie, C. Ramsay. “Protocol for a randomised controlled trial comparing laparoscopic cholecystectomy with observation/conservative management for preventing recurrent symptoms and complications in adults with uncomplicated symptomatic gallstones (C-Gall trial).” BMJ open vol. 11, no. 3, pp. e039781. Mar. 2021, doi:10.1136/bmjopen-2020-039781
[7]X. Wu, B. L. Li, C. J. Zheng. “Application of laparoscopic surgery in gallbladder carcinoma.” World J Clin Cases, vol. 11, no. 16, pp. 3694-3705. Jun. 2023. doi: 10.12998/wjcc.v11.i16.3694.
[8]D. D You, S. J Cho, O. H. Kim, J. S Song, K. S Hwang, S. C Lee, K. H Kim, H. J Choi, H. E Hong, H Seo, T H Hong, J. H Park, T. Y Lee, J Ahn J. K, Jung, K. Y Jung, S. J Kim. “Superior gallstone dissolubility and safety of tert-amyl ethyl ether over methyl-tertiary butyl ether.” WJG, vol. 25, no. 39, pp. 5936-5952. Oct. 2019.doi:10.3748/wjg.v25.i39.5936
[9]Z. Zhu, K. Luo, Zhang, G. Wang, K. Guo, P. Huang, Q. Liu. “Risk factor analysis and construction of pred Biction models of gallbladder carcinoma in patients with gallstones.” Frontiers in oncology. vol. 13, pp. 1037194. 27 Feb. 2023. doi:10.3389/fonc.2023.1037194
[10]X. Guo, Y. Li, H. Lin, L. Cheng, Z. Huang, Z. Lin, N. Mao, B. Sun, G. Wang, Q. Tang. “A nomogram for clinical estimation of acute biliary pancreatitis risk among patients with symptomatic gallstones: A retrospective case-control study.” FRONT CELL INFECT MI. vol. 12, pp. 935927. Aug. 2022. doi:10.3389/fcimb.2022.935927
[11]H. H. Wang, P. Portincasa, D. Q. Wang. “Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.” CURR MED CHEM. vol. 26, no. 19, pp. 3407-3423. 2019. doi:10.2174/0929867324666170619104801
[12]N. K. Pallaneeandee, S. S. Govindan, J. L. Zi. “Evaluation of the Common bile duct (CBD) Diameter After Laparoscopic Cholecystectomy (LC) and Laparoscopic Common Bile Duct Exploration (LCBDE): A Retrospective Study.” Surg Laparosc Endosc Percutan Tech. Vol. 33, no. 1, pp. 62-68. Feb. 2023. doi: 10.1097/SLE.0000000000001135.
[13]Y. -H. Chang, M. -Y. Lin, M. -T. Hsieh, M. -C. Ou, C. -R. Huang and B. -S. Sheu, "Multiple Field-of-View Based Attention Driven Network for Weakly Supervised Common Bile Duct Stone Detection," in IEEE Journal of Translational Engineering in Health and Medicine, vol. 11, pp. 394-404, 2023, doi: 10.1109/JTEHM.2023.3286423.
[14]N. Yang, Q. Y. Tao, J. Y. Niu, H. Sun, Y. He, Y. B. Hou, H. Luo, Z. Zhang, J. M. Yu. “Effect of a Local Anesthetic Injection Kit on Pain Relief and Postoperative Recovery After Transumbilical Single-Incision Laparoscopic Cholecystectomy.” J Pain Res, vol. 16, pp. 2791-2801.Aug. 2023, doi:10.2147/JPR.S422454
[15]S. T. Himi, N. T. Monalisa, M. Whaiduzzaman, A. Barros and M. S. Uddin, "MedAi: A Smartwatch-Based Application Framework for the Prediction of Common Diseases Using Machine Learning," in IEEE Access, vol. 11, pp. 12342-12359, 2023, doi: 10.1109/ACCESS.2023.3236002.
[16]B. Wingfield, S. Coleman, T. McGinnity and A. Bjourson, "Robust Microbial Markers for Non-Invasive Inflammatory Bowel Disease Identification," in IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 16, no. 6, pp. 2078-2088, 1 Nov.-Dec. 2019, doi: 10.1109/TCBB.2018.2831212.
[17]F. López-Caamal and H. J. Huber, "Stable IL- 1β 1β-Activation in an Inflammasome Signalling Model Depends on Positive and Negative Feedbacks and Tight Regulation of Protein Production," in IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 16, no. 2, pp. 627-637, 1 March-April 2019, doi: 10.1109/TCBB.2018.2794971.
[18]S. Ullah, BH. Yang, D. Liu, XY. Lu, ZZ. Liu, LX. Zhao, JY. Zhang, BR. Liu, "Are laparoscopic cholecystectomy and natural orifice transluminal endoscopic surgery gallbladder preserving cholecystolithotomy truly comparable? A propensity matched study." World J Gastrointest Surg. Vol. 14, no.5, pp. 470-481, May 2022, doi: 10.4240/wjgs.v14.i5.470. PMID: 35734621; PMCID: PMC9160690.
[19]A. Mulliri, B. Menahem, A. Alves, B. Dupont. “Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials”. J GASTROENTEROL, vol. 57, no. 8, pp. 529-539. Jun 2022.https://doi.org/10.1007/s00535-022-01886-4
[20]A. Fujinaga, Y, Iwashita Tada K, et al. “Efficacy of releasing impacted gallstones after percutaneous transhepatic gallbladder drainage for acute cholecystitis and consideration of the surgical difficulty during laparoscopic cholecystectomy”. Journal of Hepato‐Biliary‐Pancreatic Sciences, 2021, vol. 28, no. 11, pp. 993-999, https://doi.org/10.1002/jhbp.857
[21]H. Han, L. Zhang, Q. Fu, B. Zhang, J. Chen. “Plasma Exosomes Aggravate Acute Pancreatitis by Promoting M1 Polarization of Adipose Tissue Macrophages in Obesity-Related Severe Acute Pancreatitis”. Dig Dis Sci vol. 68, pp. 3660-3670, Jul. 2023, https://doi.org/10.1007/s10620-023-08021-0
[22]N. A. . Uygunovich, “Effectiveness Mininvasive Laparoscopic Cholecystectomy during the Complication of Acute Cholecystitis”, RJTDS, vol. 1, no. 11, pp. 20–28, Nov. 2022.
[23]K. Iqbal, S. Nawaz Durrani, F. ur . Rahman, I. . Khan, K. . ., and M. . Attique Sadiq, “Incidence of Biliary Leakage and Spilled Gallstones in Laparoscopic Cholecystectomy: Biliary Leakage and Spilled Gallstones Incidence”, PBMJ, vol. 5, no. 6, pp. 178–181, Jun. 2022.
[24R. ]Iwase, H. Shiba, K. Haruki, Y. Fujiwara, K. Furukawa, Y. Futagawa, S. Wakiyama, T. Misawa, T. Misawa. “Macroscopic Inflammation Status of Resected Gallbladder Predicts Therapeutic Outcome After Radical Resection for Gallbladder Carcinoma.” International Surgery, vol. 106, no. 4, pp. 163-170. Nov. 2022. https://doi.org/10.9738/INTSURG-D-18-00013.1
[25]J. Zhu, G. Wang, B. Xie, Y. J. Zheng, D. X. Wei, L. Yong. “Minimally invasive management of concomitant gallstones and common bile duct stones: an updated network meta-analysis of randomized controlled trials.” Surgical Endoscopy, vol. 37, no. 3. pp. 1683-1693. Oct. 2023. https://doi.org/10.1007/s00464-022-09723-8
[26]J. CHEN, Y. CUI. “Clinical study of Chaishao-Shugan-Lidan-Paishi Decoction assisted laparoscopic cholecystectomy in the treatment of chronic cholecystitis with gallstones”. Int J Trad Chin Med, no. 6, pp. 340-344, 2021.
[27]M. . Bilawal Khan, A. . Khan, Z. . Ahmad Khan, K. . Khan, M. . Waqas Khan, and K. . Rehman, “Frequency of Port Site Infection After Laparoscopic Cholecystectomy: Port Site Infection and Laparoscopic Cholecystectomy”, PJHS, vol. 3, no. 06, pp. 267–271, Nov. 2022.
[28]R. Ghani, S. . Emad, S. . Perwaiz Khan, U. . Naseeb, F. Ahmed, and S. . Zia, “Liver Enzyme Correlated with C-Reactive Protein as a Biomarker of Metabolic Syndrome in Elderly Patients: Metabolic Syndrome Related with Liver Enzyme and CRP”, PJHS, vol. 4, no. 05, pp. 280–284, May 2023.
[29]L. Zhuang, Y. Li, L. Zhang, X. Xu, D. Sun, D. Xi, Y. A. Lu. “A comparison of the therapeutic outcomes between primary duct closure and T-tube drainage after laparoscopic common bile duct exploration: a single-centre retrospective study.” Wideochirurgia i inne techniki maloinwazyjne, vol. 18, no. 1, pp. 108-116. Mar. 2023.doi:10.5114/wiitm.2022.120672
[30]H S Ahn, H J Kim, T U Kang, S M Park. “Cholecystectomy reduces the risk of cholangiocarcinoma in patients with complicated gallstones, but has negligible effect on hepatocellular carcinoma”. J GASTROEN HEPATOL, 2022, vol. 37, no. 4, Dec. 2022, pp. 669-677. https://doi.org/10.1111/jgh.15759
Copyright (c) 2025 Gaoqiang Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.